These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17419407)

  • 1. [Efficacy of lipid reduction therapy in patients with coronary disease].
    Saito S; Takayama T; Hone J; Hirayama A
    Nihon Naika Gakkai Zasshi; 2007 Mar; 96(3):435-40. PubMed ID: 17419407
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin therapy in older persons: pertinent issues.
    Grundy SM
    Arch Intern Med; 2002 Jun; 162(12):1329-31. PubMed ID: 12076230
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid-lowering therapy in patients with coronary artery disease: sex or age bias?
    Sgadari A; Incalzi RA; Onder G; Pedone C; Gambassi G
    Arch Intern Med; 2000 Sep; 160(17):2684-5. PubMed ID: 10999995
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stroke prevention by statins].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2002 May; 60(5):993-1001. PubMed ID: 12030004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid management among coronary artery disease patients with diabetes mellitus or advanced age.
    Massing MW; Sueta CA; Chowdhury M; Biggs DP; Simpson RJ
    Am J Cardiol; 2001 Mar; 87(5):646-9, A10. PubMed ID: 11230856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins: effects beyond cholesterol lowering.
    Massy ZA; Guijarro C
    Nephrol Dial Transplant; 2001 Sep; 16(9):1738-41. PubMed ID: 11522848
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipids: new guidelines, intensive treatment, and future directions.
    Jones PH
    Tex Heart Inst J; 2006; 33(2):180-3. PubMed ID: 16878620
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology and therapeutics of lipid-lowering drugs.
    Hunninghake DB
    Am Pharm; 1987 Nov; NS27(11):S18-25. PubMed ID: 3425537
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
    Fruchart JC; Brewer HB; Leitersdorf E
    Am J Cardiol; 1998 Apr; 81(7):912-7. PubMed ID: 9555782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U; Weintraub WS; Packard CJ
    Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins and risk of coronary heart disease.
    Clemenson ND
    JAMA; 2000 Jun; 283(22):2935; author reply 2936. PubMed ID: 10865266
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins and risk of coronary heart disease.
    Ebrahim S; Smith GD
    JAMA; 2000 Jun; 283(22):2935-6. PubMed ID: 10865267
    [No Abstract]   [Full Text] [Related]  

  • 13. Gauging the impact of statins using number needed to treat.
    Kumana CR; Cheung BM; Lauder IJ
    JAMA; 1999 Nov; 282(20):1899-901. PubMed ID: 10580441
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.
    Jolain B; Pettitt D
    Clin Ther; 1995; 17(3):572-80. PubMed ID: 7585861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current evidence about lipid-lowering therapy and coronary plaque].
    Otake H; Hirata K
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():95-102. PubMed ID: 22518972
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose statins in acute coronary syndromes: not just lipid levels.
    Nissen SE
    JAMA; 2004 Sep; 292(11):1365-7. PubMed ID: 15337731
    [No Abstract]   [Full Text] [Related]  

  • 17. How do prescribing doctors anticipate the effect of statins?
    Lytsy P; Burell G; Westerling R
    J Eval Clin Pract; 2011 Jun; 17(3):420-8. PubMed ID: 20545813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid-lowering drugs: focus on HMG-CoA reductase inhibitors. Introduction.
    Thompson GR
    Atherosclerosis; 1991 Dec; 91 Suppl():S1-2. PubMed ID: 1789811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.